AI or Artificial Intelligence is thought to revolutionize many industries including healthcare. There are however many risks of AI in the health care sector. These include concerns such as the ethical collection and use of healthcare data, biases encoded in algorithms, risks to patient safety, and cybersecurity. AI oversight and regulation are desired by members of the AI industry and FDA has begun this oversight. This webinar will consider the FDA’s recommendations for a predetermined change control plan as part of the marketing submission for AI/machine learning-enabled device software functions in the medical space.
WHY SHOULD YOU ATTEND?
Are you an AI university researcher, software or biomedical engineer, software programmer, developer, executive, or start-up entrepreneur in the field of medical devices such as radiology, and plan on designing, marketing, or maintaining an FDA-compliant AI machine learning software for use in health care? Are you a regulatory affairs professional working on regulatory submissions to the FDA in the medical device space? Are you interested in entering the above fields of work of regulatory affairs, engineering, software, and AI development? Are you just interested in knowing your AI bill of rights as an
American? If you answered yes to any of the above, this webinar is for you. AI and machine learning software are used more and more in the healthcare industry. There are, as of 03 July 2023, 521 AI/machine learning enabled devices approved by the FDA. A major area where AI machine learning software is involved is in the field of radiology. For instance, AI software may automatically segment, quantify, and report on different cardiac function measurements from MR scans. AI machine learning software may be used for image viewing, processing, and analysis and support health care practitioners
with their surgical procedures or with diagnosis. What is required for FDA approval of AI machine learning software? What are the FDA’s expectations and concerns? FDA has determined that the marketing submission for AI machine learning software includes a predetermined change control plan for approval and the continued safe and effective performance of the AI/machine learning-enabled device software post-approval. This webinar will explore this topic.
AREA COVERED
- Machine Learning, AI & Machine Learning – Device Software Functions
- AI Bill of Rights for all Americans and design & development considerations for AI/machine learning software
- Marketing Submission Considerations for a FDA recommended Predetermined Change Control Plan (PCCP)
- Types of modifications for inclusion in a PCCP
- PCCP Contents
- Modification Protocol, Traceability & Impact Assessment for modifications to Machine Learning models/algorithms
- Data management practices, Retraining Practices, Performance Evaluation Protocols & Update Procedures for Machine Learning Device Software Functions
- Examples of Medical Devices & Hypothetical Scenarios when modifications to ML model/algorithm are FDA compliant versus when a new marketing submission is needed
LEARNING OBJECTIVES
The US FDA has determined that a predetermined change control plan or PCCP be included in the marketing submission for medical device software that incorporates AI or machine learning models and algorithms. Manufacturers of AI or machine learning software devices are to anticipate or foresee potential modifications post FDA approval and these could be based on perceived risks foreseen or effectiveness improvements expected from anticipated forthcoming data. Manufacturers need not submit a new marketing submission for proposed modifications if they are already included and implemented under an FDA-authorized PCCP. Incorporating a PCCP is a key regulatory strategy to saving manufacturers time and costs and accelerating and improving their device's overall performance. This webinar seeks to provide input as to the data management and retraining practices, performance evaluation protocol, and update procedures that are to form the PCCP in a marketing submission. Using Golden Nuggets effectively How to deliver the ultimate client experience Understanding five core emotions Understanding “The Magic of Thinking Big” Establishing and avoiding the failure disease
WHO WILL BENEFIT?
- AI software companies in the medical device industry – executives, entrepreneurs, engineers, developers, programmers, research & development personnel
- Medical device companies – executives, entrepreneurs, engineers, developers, programmers, research & development personnel
- Regulatory Affairs Professionals in medical device and AI companies
- Software engineers, biomedical engineers, software developers, programmers,
- IT personnel of AI machine learning software
- AI researchers and students at universities
- Students in regulatory programs
Are you an AI university researcher, software or biomedical engineer, software programmer, developer, executive, or start-up entrepreneur in the field of medical devices such as radiology, and plan on designing, marketing, or maintaining an FDA-compliant AI machine learning software for use in health care? Are you a regulatory affairs professional working on regulatory submissions to the FDA in the medical device space? Are you interested in entering the above fields of work of regulatory affairs, engineering, software, and AI development? Are you just interested in knowing your AI bill of rights as an
American? If you answered yes to any of the above, this webinar is for you. AI and machine learning software are used more and more in the healthcare industry. There are, as of 03 July 2023, 521 AI/machine learning enabled devices approved by the FDA. A major area where AI machine learning software is involved is in the field of radiology. For instance, AI software may automatically segment, quantify, and report on different cardiac function measurements from MR scans. AI machine learning software may be used for image viewing, processing, and analysis and support health care practitioners
with their surgical procedures or with diagnosis. What is required for FDA approval of AI machine learning software? What are the FDA’s expectations and concerns? FDA has determined that the marketing submission for AI machine learning software includes a predetermined change control plan for approval and the continued safe and effective performance of the AI/machine learning-enabled device software post-approval. This webinar will explore this topic.
- Machine Learning, AI & Machine Learning – Device Software Functions
- AI Bill of Rights for all Americans and design & development considerations for AI/machine learning software
- Marketing Submission Considerations for a FDA recommended Predetermined Change Control Plan (PCCP)
- Types of modifications for inclusion in a PCCP
- PCCP Contents
- Modification Protocol, Traceability & Impact Assessment for modifications to Machine Learning models/algorithms
- Data management practices, Retraining Practices, Performance Evaluation Protocols & Update Procedures for Machine Learning Device Software Functions
- Examples of Medical Devices & Hypothetical Scenarios when modifications to ML model/algorithm are FDA compliant versus when a new marketing submission is needed
The US FDA has determined that a predetermined change control plan or PCCP be included in the marketing submission for medical device software that incorporates AI or machine learning models and algorithms. Manufacturers of AI or machine learning software devices are to anticipate or foresee potential modifications post FDA approval and these could be based on perceived risks foreseen or effectiveness improvements expected from anticipated forthcoming data. Manufacturers need not submit a new marketing submission for proposed modifications if they are already included and implemented under an FDA-authorized PCCP. Incorporating a PCCP is a key regulatory strategy to saving manufacturers time and costs and accelerating and improving their device's overall performance. This webinar seeks to provide input as to the data management and retraining practices, performance evaluation protocol, and update procedures that are to form the PCCP in a marketing submission. Using Golden Nuggets effectively How to deliver the ultimate client experience Understanding five core emotions Understanding “The Magic of Thinking Big” Establishing and avoiding the failure disease
- AI software companies in the medical device industry – executives, entrepreneurs, engineers, developers, programmers, research & development personnel
- Medical device companies – executives, entrepreneurs, engineers, developers, programmers, research & development personnel
- Regulatory Affairs Professionals in medical device and AI companies
- Software engineers, biomedical engineers, software developers, programmers,
- IT personnel of AI machine learning software
- AI researchers and students at universities
- Students in regulatory programs
Speaker Profile
Rachelle D’Souza began her career in regulatory compliance in 2007. She has provided Regulatory Affairs, Quality Assurance, Clinical, Pharmacovigilance and Medical Information support to the Pharmaceutical, Biologic, Generic, Natural Health Product, Dietary Supplement, Medical Device, Cosmetic, Pesticide and Food industries.Rachelle has developed regulatory strategies, independently prepared regulatory submissions and secured product and site approvals from global regulatory agencies. She has also designed, implemented, and maintained global quality, pharmacovigilance and medical information systems. Rachelle’s regulatory articles and webinars on the latest globalregulatory developments have been published in print and online by regulatory professional associations, webinar hosting platforms and industry magazines.
Upcoming Webinars
California Meal and Rest Breaks: What You Dont Know Can Cos…
Responding to EEOC Discrimination Charges-What's Your Busin…
Implementing an Effective Human Error Reduction Program
Conflict Resolution - Prevent, De-escalate, Resolve
When Employees Travel: Wage and Expense Rules Employers Mus…
With Mandatory Paid Leave Gaining Ground Is It Time To Do A…
Female to Female Hostility @Workplace: All you Need to Know
Form 1099-MISC and 1099-NEC Compliance Update 2024
Validation Statistics for Non-Statisticians
The Totally Organized Professional Is All About Outcomes
Why EBITDA Doesn't Spell Cash Flow and What Does
GAMP5, Second Edition and Alignment with Computer Software …
Project Management for Non-Project Managers - Scheduling yo…
Sunshine Act Reporting - Clarification for Clinical Research
Understanding the Math of HR… So You Can Show How HR Impact…
FFIEC BSA/AML Examination Manual: What Compliance Officers …
How to Address ISO's New Climate Change Requirements
I-9 Audits: Strengthening Your Immigration Compliance Strat…
Re-imagine Finance & Accounting Made Simple. Three Webinars…
Stay Interviews: A Powerful and Low-Cost Employee Engagemen…
How To Conduct An Internal Harassment And Bullying Investig…
Effective Onboarding: How to Welcome, Engage, and Retain Ne…
Managing Toxic & Other Employees Who Have Attitude Issues
Analytical Method Validation Under Good Laboratory Practic…
Do's and Don'ts of Documenting Employee Behaviour, Performa…
Do's and Don'ts of Giving Effective Feedback for Performanc…
Onboarding New Hires: Leverage the Potential of Artificial …
Project Management for HR, Administrative Professionals, an…
Tattoos, hijabs, piercings, and pink hair: The challenges …
Using Behavior Based Interviewing for Finding the Best Matc…
How to Document Employee Discussions and Why it is Important
Stressed Out: How to Handle Conflict, Difficult People and …
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Best Practices for Working With Vendors and Suppliers
Understanding the Artificial Intelligence Landscape
Marketing to Medicare or Medicaid Beneficiaries - What You …
Accounting For Non Accountants : Debit, Credits And Financi…
Principles & Practices for the Cybersecurity of Legacy Medi…
Independent Contractor vs. Employee New Rule Issued by The …
Ultimate Persuasion Strategies! - Secret Influence Tools & …
Kicking your Employee Retention Efforts into Overdrive: Sta…